Product Information
CLIND PH-BENZOYL PEROX 1.2-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.4106 per GM under NDC 45802073684. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 10 mg/g; mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802073684
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA090979FDA Approved
6/26/2012
TE Code
AB
On Market Since
6/26/2012
Pharmacological Classes
Price Statistics
The NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4106 per GM |
|---|---|
| All-time high | $3.4311 (Apr 13, 2016) |
| All-time low | $0.3909 (Jul 22, 2026) |
| 52-week high | $0.5354 |
| 52-week low | $0.3909 |
| Median price | $1.0603 |
| Average price | $1.5518 |
| Largest weekly change | +44.6% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clindamycin, Benzoyl Peroxide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin, Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLIND PH-BENZOYL PEROX 1.2-5%?
The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PEROX 1.2-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.4106 per GM (NDC 45802073684), effective Sep 30, 2026.
How has the price of CLIND PH-BENZOYL PEROX 1.2-5% changed over time?
Over the history we have for it, the NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has declined 85.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PEROX 1.2-5%?
Since Nov 28, 2013, the NADAC for CLIND PH-BENZOYL PEROX 1.2-5% has ranged from a low of $0.3909 (Jul 22, 2026) to a high of $3.4311 (Apr 13, 2016), with a median of $1.0603 per GM.
Are there cheaper alternatives to CLIND PH-BENZOYL PEROX 1.2-5%?
No other NADAC-published product currently shares the active ingredient and strength of CLIND PH-BENZOYL PEROX 1.2-5% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLIND PH-BENZOYL PEROX 1.2-5%?
CLIND PH-BENZOYL PEROX 1.2-5% (NDC 45802073684) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.